
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We leverage our deep expertise in immune-system activation to advance a focused pipeline of individualized and targeted approaches against solid tumors. Our focus is on earlier-stage development, with a sweet spot in bringing assets through discovery and pre-clinical development and into clinical trials. We launched in 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics. Our highly motivated team of 35 people has deep expertise across the biotechnology value chain, with in-house...
Biotech,precision medicine,cell therapy,small molecule,personalised medicine,immunotherapy,novel cancer therapies,immuno-oncology,and checkpoint inhibition
Invios innovative immuno-oncology operates in the Biotechnology research industry.
Invios innovative immuno-oncology's revenue is 11m - 100m
Invios innovative immuno-oncology has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.